These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29732485)

  • 21. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
    Gupta YK; Gupta M; Kohli K
    Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of melatonin on aluminium-induced neurobehavioral and neurochemical changes in aging rats.
    Allagui MS; Feriani A; Saoudi M; Badraoui R; Bouoni Z; Nciri R; Murat JC; Elfeki A
    Food Chem Toxicol; 2014 Aug; 70():84-93. PubMed ID: 24727051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease.
    Hajieva P; Behl C
    Curr Pharm Des; 2006; 12(6):699-704. PubMed ID: 16472160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin.
    van Rensburg SJ; Daniels WM; Potocnik FC; van Zyl JM; Taljaard JJ; Emsley RA
    S Afr Med J; 1997 Sep; 87(9):1111-5. PubMed ID: 9358827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum.
    Garcia T; Esparza JL; Nogués MR; Romeu M; Domingo JL; Gómez M
    Hippocampus; 2010 Jan; 20(1):218-25. PubMed ID: 19405147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development.
    Kandimalla R; Vallamkondu J; Corgiat EB; Gill KD
    Brain Pathol; 2016 Mar; 26(2):139-54. PubMed ID: 26494454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA
    J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin protects against Aβ-induced neurotoxicity in primary neurons via miR-132/PTEN/AKT/FOXO3a pathway.
    Zhao Y; Zhao R; Wu J; Wang Q; Pang K; Shi Q; Gao Q; Hu Y; Dong X; Zhang J; Sun J
    Biofactors; 2018 Nov; 44(6):609-618. PubMed ID: 29322615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
    Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
    Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders.
    Miller E; Morel A; Saso L; Saluk J
    Curr Top Med Chem; 2015; 15(2):163-9. PubMed ID: 25985818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of oxidative stress and antioxidants in neurodegenerative diseases.
    Rao AV; Balachandran B
    Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of melatonin supplementation in neurodegenerative disorders.
    Polimeni G; Esposito E; Bevelacqua V; Guarneri C; Cuzzocrea S
    Front Biosci (Landmark Ed); 2014 Jan; 19(3):429-46. PubMed ID: 24389194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
    Ali T; Kim MO
    J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin relieves the neural oxidative burden that contributes to dementias.
    Reiter RJ; Tan DX; Pappolla MA
    Ann N Y Acad Sci; 2004 Dec; 1035():179-96. PubMed ID: 15681808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protective properties of melatonin against aluminium-induced neuronal injury.
    Al-Olayan EM; El-Khadragy MF; Abdel Moneim AE
    Int J Exp Pathol; 2015 Jun; 96(3):196-202. PubMed ID: 25891353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E and other antioxidants in neuroprotection.
    Behl C
    Int J Vitam Nutr Res; 1999 May; 69(3):213-9. PubMed ID: 10389030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
    Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin.
    Tchekalarova J; Tzoneva R
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.